CCN5 is a growth arrest-specific gene that regulates smooth muscle cell proliferation and motility

American Journal of Pathology

Volumn 162, Issue 1, 2003, Pages 219-231

  Lake, Andrew C ^a   Bialik, Ann ^c   Walsh, Kenneth ^c   Castellot Jr , John J ^a,b  

^a TUFTS UNIVERSITY   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CYSTEINE RICH 61 CONNECTIVE TISSUE GROWTH FACTOR NEPHROBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CAROTID ARTERY INJURY; CELL ADHESION; CELL CULTURE; CELL GROWTH; CELL MOTILITY; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE FUNCTION; GROWTH INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SMOOTH MUSCLE FIBER;

EID: 0037221550     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63813-8     Document Type: Article

References (41)

1. Mishra-Gorur K, Delmolino LM, Castellot Jr JJ: Biological functions of heparan sulfate and heparan sulfate proteoglycans. Trends Glycosci Glycotechnol 1998, 10:193-210
2. Delmolino LM, Stearns NA, Castellot Jr JJ: Heparin induces a member of the CCN family which has characteristics of a growth arrest specific gene. Mol Biol Cell 1997, 8:287a
3. Delmolino LM, Stearns NA, Castellot Jr JJ: COP-1, a member of the CCN family, is a heparin-induced growth arrest specific gene in vascular smooth muscle cells. J Cell Physiol 2001, 188:45-55
4. Ayer-Lelievre C, Brigstock D, Lau L, Pennica D, Perbal B, Yeger H: Report and abstracts on the first international workshop on the CCN family of genes. Mol Pathol 2001, 54:105-120
5. Pennica D, Swanson TA, Welsh JW, Roy MA, Lawrence DA, Lee J, Brush J, Taneyhill LA, Deuel B, Lew M, Watanabe C, Cohen RL, Melhem MF, Finley GG, Quirke P, Goddard AD, Hillan KJ, Gurney AL, Botstein D, Levine AJ: WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc Natl Acad Sci USA 1998, 95:14717-14722
6. Inadera H, Hashimoto S, Dong HY, Suzuki T, Nagai S, Yamashita T, Toyoda N, Matsushima K: WISP-2 as a novel estrogen-responsive gene in human breast cancer cells. Biochem Biophys Res Commun 2000, 275:108-114
7. Bork P: The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett 1993, 327:125-130
8. Oemar BS, Luscher TF: Connective tissue growth factor. Friend or foe? Arterioscler Thromb Vasc Biol 1997, 17:1483-1489
9. Lau LF, Lam SC: The CCN family of angiogenic regulators: The integrin connection. Exp Cell Res 1999, 248:44-57
10. Brigstock DR: The connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family. Endocr Rev 1999, 20:189-206
11. Castellot Jr JJ, Favreau LV, Karnovsky MJ, Rosenberg RD: Inhibition of vascular smooth muscle cell growth by endothelial cell-derived heparin. Possible role of a platelet endoglycosidase. J Biol Chem 1982, 257:11256-11260
12. Castellot Jr JJ, Pukac LA, Caleb BL, Wright Jr TC, Karnovsky MJ: Heparin selectively inhibits a protein kinase C-dependent mechanism of cell cycle progression in calf aortic smooth muscle cells [published erratum appears in J Cell Biol 1990,110:863]. J Cell Biol 1989, 109: 3147-3155
13. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B: A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 1998, 95:2509-2514
14. Clowes AW, Reidy MA, Clowes MM: Kinetics of cellular proliferation after arterial injury. I Smooth muscle growth in the absence of endothelium. Lab Invest 1983, 49:327-333
15. Wei GL, Krasinski K, Kearney M, Isner JM, Walsh K, Andres V: Temporally and spatially coordinated expression of cell cycle regulatory factors after angioplasty. Circ Res 1997, 80:418-426
16. Castellot Jr JJ, Cochran DL, Karnovsky MJ: Effect of heparin on vascular smooth muscle cells. I Cell metabolism. J Cell Physiol 1985, 124:21-28
17. Postlethwaite AE, Snyderman R, Kang AH: The chemotactic attraction of human fibroblasts to a lymphocyte-derived factor. J Exp Med 1976, 144:1188-1203
18. Grotendorst GR, Seppa HE, Kleinman HK, Martin GR: Attachment of smooth muscle cells to collagen and their migration toward platelet-derived growth factor. Proc Natl Acad Sci USA 1981, 78:3669-3672
19. Majack RA, Clowes AW: Inhibition of vascular smooth muscle cell migration by heparin-like glycosaminoglycans. J Cell Physiol 1984, 118:253-256
20. Lemire JM, Merrilees MJ, Braun KR, Wight TN: Overexpression of the V3 variant of versican alters arterial smooth muscle cell adhesion, migration, and proliferation in vitro. J Cell Physiol 2002, 190:38-45
21. Pauly RR, Passaniti A, Bilato C, Monticone R, Cheng L, Papadopoulos N, Gluzband YA, Smith L, Weinstein C, Lakatta EG: Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation. Circ Res 1994, 75:41-54
22. Zempo N, Koyama N, Kenagy RD, Lea HJ, Clowes AW: Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor. Arterioscler Thromb Vasc Biol 1996, 16:28-33
23. Palumbo R, Gaetano C, Melillo G, Toschi E, Remuzzi A, Capogrossi MC: Shear stress downregulation of platelet-derived growth factor receptor-beta and matrix metalloprotease-2 is associated with inhibition of smooth muscle cell invasion and migration. Circulation 2000, 102:225-230
24. Ellis PD, Chen Q, Barker PJ, Metcalfe JC, Kemp PR: Nov gene encodes adhesion factor for vascular smooth muscle cells and is dynamically regulated in response to vascular injury. Arterioscler Thromb Vasc Biol 2000, 20:1912-1919
25. Champagne MJ, Dumas P, Orlov SN, Bennett MR, Hamet P, Tremblay J: Protection against necrosis but not apoptosis by heat-stress proteins in vascular smooth muscle cells: Evidence for distinct modes of cell death. Hypertension 1999, 33:906-913
26. Zhang R, Averboukh L, Zhu W, Zhang H, Jo H, Dempsey PJ, Coffey RJ, Pardee AB, Liang P: Identification of rCop-1, a new member of the CCN protein family, as a negative regulator for cell transformation. Mol Cell Biol 1998, 18:6131-6141
27. Castellot Jr JJ, Addonizio ML, Rosenberg R, Karnovsky MJ: Cultured endothelial cells produce a heparinlike inhibitor of smooth muscle cell growth. J Cell Biol 1981, 90:372-379
28. Kireeva ML, Mo F-E, Yang GP, Lau LF: Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion. Mol Cell Biol 1996, 16:1326-1334
29. Kumar S, Hand AT, Connor JR, Dodds RA, Ryan PJ, Trill JJ, Fisher SM, Nuttall ME, Lipshutz DB, Zou C, Hwang SM, Votta BJ, James IE, Rieman DJ, Gowen M, Lee JC: Identification and cloning of a connective tissue growth factor-like cDNA from human osteoblasts encoding a novel regulator of osteoblast functions. J Biol Chem 1999, 274:17123-17131
30. Babic AM, Chen CC, Lau LF: Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivo. Mol Cell Biol 1999, 19:2958-2966
31. Oemar BS, Werner A, Garnier JM, Do DD, Godoy N, Nauk M, Marz W, Rupp J, Pech M, Luscher TF: Human connective tissue growth factor is expressed in advanced atherosclerotic lesions. Circulation 1997, 95:831-839
32. Bradham DM, Igarashi A, Potter RL, Grotendorst GR: Connective tissue growth factor: A cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 1991, 14:1285-1294
33. Igarashi A, Okochi H, Bradham DM, Grotendorst GR: Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell 1993, 4:637-645
34. Schwartz SM: Smooth muscle migration in vascular development and pathogenesis. Transpl Immunol 1997, 5:255-260
35. Zoubine MN, Banerjee S, Saxena NK, Campbell DR, Banerjee SK WISP-2: A serum-inducible gene differentially expressed in human normal breast epithelial cells and in MCF-7 breast tumor cells. Biochem Biophys Res Commun 2001, 282:421-425
36. Frazier K, Williams S, Kothapalli D, Klapper H, Grotendorst GR: Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol 1996, 107:404-411
37. Kireeva ML, Latinkic BV, Kolesnikova TV, Chen CC, Yang GP, Abler AS, Lau LF: Cyr61 and Fisp12 are both ECM-associated signaling molecules: Activities, metabolism, and localization during development. Exp Cell Res 1997, 233:63-77
38. Ball DK, Surveyor GA, Diehl JR, Steffen CL, Uzumcu M, Mirando MA, Brigstock DR: Characterization of 16- to 20-kilodalton (kDa) connective tissue growth factors (CTGFs) and demonstration of proteolytic activity for 38-kDa CTGF in pig uterine luminal flushings. Biol Reprod 1998, 59:828-835
39. Jedsadayanmata A, Chen CC, Kireeva ML, Lau LF, Lam SC: Activation-dependent adhesion of human platelets to Cyr61 and Fisp12/mouse connective tissue growth factor is mediated through integrin alpha(IIb)beta(3). J Biol Chem 1999, 274:24321-24327
40. Hishikawa K, Oemar BS, Tanner FC, Nakaki T, Fujii T, Luscher TF: Overexpression of connective tissue growth factor gene induces apoptosis in human aortic smooth muscle cells. Circulation 1999, 100:2108-2112
41. Hishikawa K, Oemar BS, Tanner FC, Nakaki T, Luscher TF, Fujii T: Connective tissue growth factor induces apoptosis in human breast cancer cell line MCF-7. J Biol Chem 1999, 274:37461-37466